Page last updated: 2024-10-28

hexamethylene bisacetamide and B16 Melanoma

hexamethylene bisacetamide has been researched along with B16 Melanoma in 3 studies

N,N'-diacetyl-1,6-diaminohexane: chemical name obtained from Acta Biol Hung 1990;41(1-3):199-208

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (66.67)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ickowicz Schwartz, D1
Gozlan, Y1
Greenbaum, L1
Babushkina, T1
Katcoff, DJ1
Malik, Z1
Orlow, SJ2
Chakraborty, AK2
Pawelek, JM2
Boissy, RE1

Other Studies

3 other studies available for hexamethylene bisacetamide and B16 Melanoma

ArticleYear
Differentiation-dependent photodynamic therapy regulated by porphobilinogen deaminase in B16 melanoma.
    British journal of cancer, 2004, May-04, Volume: 90, Issue:9

    Topics: Acetamides; Aminolevulinic Acid; Animals; Antineoplastic Agents; Blotting, Western; Butyrates; Cell

2004
Membrane glycoproteins common to vesicles and melanosomes in mouse melanoma cells.
    Pigment cell research, 1992, Volume: Suppl 2

    Topics: 1-Methyl-3-isobutylxanthine; Acetamides; Animals; Female; Gene Expression Regulation, Neoplastic; Im

1992
Inhibition of induced melanogenesis in Cloudman melanoma cells by four phenotypic modifiers.
    Experimental cell research, 1990, Volume: 191, Issue:2

    Topics: 1-Methyl-3-isobutylxanthine; Acetamides; Animals; Butyrates; Butyric Acid; Cell Transformation, Neop

1990